Serial #79251607
LIVE

Serial Number

79251607

Owner

Galapagos N.V.

Attorney

Alexandra MacKay

Filing Date

Sep 4, 2018

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79251607 Trademark

Serial Number: 79251607 • Registration: 5899706

Serial #79251607 is a trademark filed by Galapagos N.V. on September 4, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Galapagos N.V. (6 trademarks)

Generaal de Wittelaan L11 A3
Mechelen BE-2800 , BE

Entity Type: 03

Trademark Details

Filing Date

September 4, 2018

Registration Date

November 5, 2019

Published for Opposition

August 20, 2019

Cancellation Date

May 22, 2026

Goods & Services

pharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; biopharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes

Medical services; medical and pharmaceutical advisory and consultancy services

Medical, scientific and industrial scientific research services; pharmaceutical and biopharmaceutical research and development services; laboratory analysis and testing services in the field of gene expression; development, laboratory analysis and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis and testing of medicaments; development of test systems for pharmaceutical and biopharmaceutical products; development of databases in the medical, pharmaceutical and biopharmaceutical field and development of computer data banks containing information concerning gene expression and gene therapy; pharmaceutical drug development services

Filing History

CANCELLED SECTION 71
May 22, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 5, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
May 15, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 1, 2020 FICS
FINAL DISPOSITION PROCESSED
Feb 29, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 5, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Aug 16, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 31, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 31, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2019 NONP
ASSIGNED TO LIE
Jul 15, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 3, 2019 CNSA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 20, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 20, 2019 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 18, 2019 TROA
REFUSAL PROCESSED BY IB
Mar 16, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 28, 2019 RFCS
REFUSAL PROCESSED BY MPU
Feb 28, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Feb 23, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 20, 2019 RFCR
NON-FINAL ACTION WRITTEN
Feb 19, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 19, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 19, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 14, 2019 REPR